Saturday, November 28, 2015

Turing CEO will keep high Daraprim price for individuals

There is more controversy over prescription drug prices and Turing Pharmaceuticals CEO Martin Shkreli. Shkreli caused a public uproar when he drastically raised the price of a lifesaving drug for cancer and AIDS patients

From: http://www.cbsnews.com/videos/turing-ceo-will-keep-high-daraprim-price-for-individuals/

No comments:

Post a Comment